Thursday, June 20, 2024

🌎 ESAB Initiated, Samsara Initiated, TransUnion Upgraded and more...

Ratings changes for Enphase Energy, SolarEdge Technologies, Esperion Therapeutics, Micron Technology, Ocular Therapeutix, Iovance Biotherapeutics, United Therapeutics and more...Text "MarketBeat" to 68285 to get SMS breaking news alerts for stocks on your watchlist and other special reports. Learn More.
Unsubscribe.
MarketBeat Daily Ratings
June 20th, 2024
S and P pricesDow pricesQQQ prices
Follow MarketBeat on Twitter Join the MarketBeat Facebook Group Subscribe on YouTube 

Today's Top Stories
Celsius Stock: Why Piper Sandler Forecasts a 50% Surge
580,000 glass coffee mugs recalled because they can break when filled with hot liquid
AI "wealth window" will close June 25 (Paradigm Press)
Accenture's Stock Earnings Reveal an AI-Powered Growth Strategy
Mike Pence's foundation launches a $10 million election-year campaign to preserve Trump-era tax cuts
3 Tech Stocks Insiders, Major Shareholders, and Institutions Buy
The Supreme Court upholds a tax on foreign income over a challenge backed by business interests
Nvidia's missing link? (Porter & Company)
Top 3 Stocks to Buy Now as Energy Sector Hits Buy Zone
NATO member Romania to send a Patriot missile system to neighboring Ukraine
Autodesk Stock Up 25%, Analysts Want More Double-Digit Gains
China protests over EU move to hike tariffs on Chinese electric vehicles
3 Strong Buy Stocks for a Summer Surge
Quick Links

Your Watchlist (Manage Your Watchlist and Monitor Your Portfolio)

Analysts' Upgrades
  • ASM International (OTCMKTS:ASMIY) was upgraded by analysts at Morgan Stanley from an "equal weight" rating to an "overweight" rating.The current price is $757.65.
  • Bread Financial (NYSE:BFH) was upgraded by analysts at Evercore ISI from an "underperform" rating to an "in-line" rating. They now have a $45.00 price target on the stock, up previously from $42.00. This represents a 4.4% upside from the current price of $43.11.
  • DLocal (NASDAQ:DLO) was upgraded by analysts at UBS Group AG from a "sell" rating to a "neutral" rating. They now have a $9.00 price target on the stock, down previously from $13.00. This represents a 20.2% upside from the current price of $7.49.
  • First Quantum Minerals (OTCMKTS:FQVLF) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.The current price is $12.12.
  • HomeStreet (NASDAQ:HMST) was upgraded by analysts at Janney Montgomery Scott from a "neutral" rating to a "buy" rating. They now have a $13.50 price target on the stock. This represents a 22.4% upside from the current price of $11.03.
  • iRhythm Technologies (NASDAQ:IRTC) was upgraded by analysts at Wolfe Research from a "peer perform" rating to an "outperform" rating. They now have a $115.00 price target on the stock. This represents a 9.7% upside from the current price of $104.86.
  • Ocular Therapeutix (NASDAQ:OCUL) was upgraded by analysts at TD Cowen from a "hold" rating to a "buy" rating. They now have a $11.00 price target on the stock, up previously from $7.00. This represents a 82.7% upside from the current price of $6.02.
  • Skyworks Solutions (NASDAQ:SWKS) was upgraded by analysts at B. Riley from a "neutral" rating to a "buy" rating. They now have a $130.00 price target on the stock, up previously from $96.00. This represents a 21.2% upside from the current price of $107.28.
  • TransUnion (NYSE:TRU) was upgraded by analysts at Bank of America Co. from a "neutral" rating to a "buy" rating. They now have a $92.00 price target on the stock. This represents a 24.3% upside from the current price of $74.00.
  • Williams Companies (NYSE:WMB) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.The current price is $42.35.
  • View today's most recent analysts' upgrades at MarketBeat.com right arrow


Analysts' Downgrades
  • British Land (OTCMKTS:BTLCY) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.The current price is $5.41.
  • Deutsche Lufthansa (OTCMKTS:DLAKY) was downgraded by analysts at Stifel Nicolaus from a "buy" rating to a "hold" rating.The current price is $6.47.
  • Esperion Therapeutics (NASDAQ:ESPR) was downgraded by analysts at Bank of America Co. from a "neutral" rating to an "underperform" rating. They now have a $2.50 price target on the stock, down previously from $2.90. This represents a 7.3% upside from the current price of $2.33.
  • Prelude Therapeutics (NASDAQ:PRLD) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating. They now have a $3.00 price target on the stock. This represents a 19.4% downside from the current price of $3.72.
  • Ryanair (NASDAQ:RYAAY) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating.The current price is $114.97.
  • Wärtsilä Oyj Abp (OTCMKTS:WRTBY) was downgraded by analysts at Deutsche Bank Aktiengesellschaft from a "buy" rating to a "hold" rating.The current price is $4.44.
  • Zentalis Pharmaceuticals (NASDAQ:ZNTL) was downgraded by analysts at UBS Group AG from a "buy" rating to a "neutral" rating. They now have a $5.00 price target on the stock, down previously from $28.00. This represents a 8.6% downside from the current price of $5.47.
  • View today's most recent analysts' downgrades at MarketBeat.com right arrow


Analysts' New Coverage
  • Birkenstock (NYSE:BIRK) is now covered by analysts at BNP Paribas. They set an "outperform" rating and a $68.00 price target on the stock. This represents a 11.5% upside from the current price of $60.99.
  • ESAB (NYSE:ESAB) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $115.00 price target on the stock. This represents a 19.4% upside from the current price of $96.29.
  • Samsara (NYSE:IOT) is now covered by analysts at Bank of America Co.. They set a "buy" rating and a $37.00 price target on the stock. This represents a 25.2% upside from the current price of $29.55.
  • Vericel (NASDAQ:VCEL) is now covered by analysts at TD Cowen. They set a "buy" rating and a $55.00 price target on the stock. This represents a 22.7% upside from the current price of $44.81.
  • Virios Therapeutics (NASDAQ:VIRI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $1.00 price target on the stock. This represents a 308.5% upside from the current price of $0.24.
  • Vodafone Group Public (NASDAQ:VOD) is now covered by analysts at Deutsche Bank Aktiengesellschaft. They set a "buy" rating on the stock.The current price is $9.10.
  • View today's most recent analysts' new coverage at MarketBeat.com right arrow

Upgrade Your Subscription
Manage Your Watchlist
Join Our Facebook Group

Thank you for subscribing to MarketBeat!
We empower individual investors to make better trading decisions by providing real-time financial information and objective market research. MarketBeat is a small business and email is a crucial tool for us to share information, news, trading ideas and financial products and services with our subscribers (that's you!). If you have questions about your subscription, feel free to contact our U.S. based support team via email at contact@marketbeat.com.
 
If you would like to unsubscribe or change which emails you receive, you can manage your mailing preferences or unsubscribe from these emails.
 
© 2006-2024 MarketBeat Media, LLC.
345 N Reid Place, Suite 620, Sioux Falls, SD 57103. United States.
 
Today's Bonus Content: These Automated Options are a game changer (Click to Opt-in)
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Why the "January Effect" could signal a market reversal!

Watch out for this as we wrap up the year! ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏  ͏...